The latest news from Latin America

Provided by AGP

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on April 29, 2026

Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
ARMOUR Families & Facing Fentanyl Partner with National FOP to Expand Prevention, Education, and Life-Saving Efforts
Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana
Banco Itaú Chile and its New York Branch upgraded to ‘A-’ by S&P Global Ratings
Strategic Role of Specialized Translation in Global Marketing Communication and Brand Consistency
Sapho Bio Secures $5M, Advances Rapid Sterility Testing Through USP<1223> Validation
Olas Sonoras 2026: El Festival de Música que Está Marcando el Ritmo del Caribe Colombiano
Genesis FX Markets Launches AI-Integrated Trading Platform for Retail Traders
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
Nearly Half a Million Users Utilize Bitget’s AI-Trading Infrastructure, Messari Report Highlights
Codexis to share RNA manufacturing advances at TIDES USA
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
Century Aluminum Sets Date for First Quarter 2026 Earnings Announcement
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET
ALPHAMIN ANNOUNCES CAD$0.13 PER SHARE FINAL FY2025 DIVIDEND/ FILES Q1 2026 FINANCIAL STATEMENTS AND MD&A
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias
UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026

Share us

on your social networks:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.